Stewart, E. A., Diamond, M. P., Williams, A. R. W., Carr, B. R., Myers, E. R., Feldman, R. A., . . . Chwalisz, K. (2019). Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: Pooled analysis of two 12-month, placebo-controlled, randomized trials. Hum Reprod.
Stile di citazione ChicagoStewart, E A., et al. "Safety and Efficacy of the Selective Progesterone Receptor Modulator Asoprisnil for Heavy Menstrual Bleeding With Uterine Fibroids: Pooled Analysis of Two 12-month, Placebo-controlled, Randomized Trials." Hum Reprod 2019.
Citazione MLAStewart, E A., et al. "Safety and Efficacy of the Selective Progesterone Receptor Modulator Asoprisnil for Heavy Menstrual Bleeding With Uterine Fibroids: Pooled Analysis of Two 12-month, Placebo-controlled, Randomized Trials." Hum Reprod 2019.